SynteractHCR Deutschland GmbH
In early 2013, San Diego-based Synteract acquired Munich-based Harrison Clinical Research, forming SynteractHCR, a top tier international contract research organization. Through our expanded capabilities we support clinical trials globally, handling everything from emerging products through post-marketing. SynteractHCR is a full-service CRO with a successful track record of more than two decades supporting pharmaceutical, biotechnology and medical device companies in all phases of clinical development, across multiple therapeutic areas. We work closely with you to customize programs, using our Intelligent Clinical Development (ICD+) approach to deliver timely, high quality data to help you get to decision points faster.
Forschung & Lehre